Pyridazine derivatives useful as vanilloid receptor ligands

Compounds having the general structure and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic d...

Full description

Saved in:
Bibliographic Details
Main Authors DOHERTY, ELIZABETH M, CHEN, NING, NIXEY, THOMAS, OGNYANOV, VASSIL I, NORMAN, MARK H, STEC, MARKIAN, HULME, CHRISTOPHER, CHAKRABARTI, PARTHA P, PETTUS, LIPING H, FALSEY, JAMES RICHARD, FOTSH, CHRISTOPHER H, KATON, JODIE, RZASA, ROBERT MICHAEL, DOMINGUEZ, CELIA, ZHU, JIAWANG, WANG, HUI-LING
Format Patent
LanguageEnglish
French
German
Published 05.01.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compounds having the general structure and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders. or any pharmaceutically-acceptable salt thereof, wherein: J is O or S; X is = C(R 2 ); Y is N;
Bibliography:Application Number: EP20100008426